Background: Antibodies targeting variant antigens expressed on the surface of Plasmodium falciparum infected erythrocytes have been associated with protection from clinical malaria. The precise target for these antibodies is unknown. The best characterized and most likely target is the erythrocyte surface-expressed variant protein family Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1).
Background
Maintaining Plasmodium falciparum infections whilst limiting morbidity and mortality is a feature of the non-sterile immunity acquired by individuals living in malaria endemic areas. Studies whereby antibodies were passively transferred from immune to non-immune individuals suggested this immunity is, at least in part, antibodymediated [1, 2] . Humans exposed to malaria can mount an antibody response to many parasite antigens including those present on the sporozoite, merozoite and those on the surface of the infected erythrocyte [3] [4] [5] . Parasite induced antigens on the infected red cell surface are potentially important targets for protective immunity because they are exposed for long periods of the erythrocytic cycle and serve critical biological functions [6] . Following infection children mount antibodies directed against the infected erythrocyte surface, specific to the infecting isolate [7] [8] [9] [10] and such antibodies are associated with protection from subsequent clinical malaria with the homologous parasite [8] .
The most extensively characterized of the proteins expressed at the infected red cell surface are the products of the var genes, Plasmodium falciparum erythrocyte membrane protein 1, (PfEMP1) [11] . PfEMP1 is a family of extracellular, highly polymorphic and clonally variant adhesion molecules [12] [13] [14] [15] [16] . They are expressed on the surface of the red cell at around 18 hours after invasion and remain present throughout the second half of the intra-erythrocytic cycle [12] . They exhibit a domain structure and the domains bear homology to the cysteine-rich binding domains of varied Plasmodium molecules involved in the binding to and invasion of erythrocytes; EBA-175, the P. falciparum glycophorin A receptor and the Plasmodium vivax and Plasmodium knowlesi ligands that allow invasion of Duffy blood-group positive erythrocytes [17] [18] [19] . These domains are called Duffy-binding like domains (DBL) and they are interspersed with regions containing multiple cysteine residues termed the cysteinerich interdomain regions (CIDR).
Using a panel of recombinant proteins corresponding to the domains of one particular PfEMP1 protein, A4 PfEMP1 from the A4 laboratory parasite line, domain-specific antibodies prior to the transmission season in two communities in Kenya with differing transmission characteristics were measured. The presence of these antibodies was related to the likelihood of experiencing clinical malaria during the subsequent transmission season. It was shown that humans are capable of mounting anti-PfEMP1 domain-specific antibodies and that the prevalence of these antibodies is related to exposure. Furthermore responses to one recombinant domain, DBL4γ, show evidence of cross-reactivity or perhaps are being directed at a more conserved epitope.
Materials and methods

Study population
This work was carried out at the Kenya Medical Research Institute, Centre for Geographic Medicine Research Coast situated at Kilifi District Hospital, 50 km north of Mombasa on the coast of Kenya. The hospital serves around 240,000 people living north and south of an ocean creek. Individuals investigated during these immuno-epidemiological studies were resident in two sites in Kilifi District (within 20 km of each other), Chonyi and Ngerenya. These study sites have been described in detail elsewhere [20] . Inhabitants of these areas are predominantly Mijikenda, sharing similar beliefs and customs. Residents of Ngerenya receive, on average 10 infective bites/person/ year, [21] , whereas residents of Chonyi have an estimated 50 bites/person/year [22] . The annual incidence of clinical malaria among the two communities varied with both age and area. In children less than one year of age, the incidence was higher in Chonyi than in Ngerenya (IRR 1.56 [95% CI 1.18-2.06]p = 0.002), there was no difference between the two areas in children aged 1-3 years and in those aged 4 -19 years the incidence was higher in Ngerenya (IRR 0.45 [95% CI 0.4-0.51]p = 0.001) [20] .
Sample collection
Sera collection and active surveillance were conducted as part of a study examining the clinical epidemiology of malaria under differing transmission conditions [20] . In brief, serum was collected in October 2000 from 1,222 individuals resident in both areas aged between six months and 85 years. A blood slide was prepared for every individual in the cohort at the time of serum collection in order to define their pre-clinical surveillance status as parasite positive or negative. All individuals included in this study were asymptomatic and afebrile at the time of crosssectional survey. The cohorts were then followed for evidence of malaria by weekly active surveillance for fever. Malaria was defined as a febrile episode with an axillary temperature greater than 37.5°C and a parasitaemia of greater than 2500 parasites/μl above one year of age, and fever plus any parasitaemia below a year. These have been determined to be sensitive and specific malaria case-definitions in both study communities [20] . Twenty nonmalaria exposed control sera were collected from Oxford, UK.
The parasite clone A4 having undergone prior selection with BC6 is denoted A4U. In addition two further laboratory clones, A4 40-cycle (parasites of the A4 lineage which have been left in culture for 40 cycles with no selection) and 3D7, and one clinical isolate, P1, obtained from a five year old child admitted to Kilifi District Hospital with moderately severe malaria were used to investigate antibody reactivity against the intact infected erythrocyte by flow cytometry. Using the monoclonal antibody BC6, flow cytometry demonstrated expression of the A4 var gene of between 88-95% in A4U parasites and between 11 and 25% in A4-40 cycle parasites. There was no recognition of either 3D7 or P1 with BC6. PCR fragments corresponding to each domain were purified using a QIAquick PCR purification kit (Qiagen, Hilden, Germany) and were ligated into pCR 2.1 vector (Invitrogen), containing the α-peptide of b-galactosidase to allow bluewhite selection in the presence of 5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-Gal). Sub-cloning efficiency cells DH5α were transformed and positive recombinant clones were identified by loss of α-complementation. Transformants were checked, by PCR performed with vector-specific primers, for the presence of domain-specific DNA and the plasmid DNA was purified using Wizard Plus SV Minipreps (Qiagen, Hilden, Germany). Purified pCR 2.1 plasmids containing individual domains were digested with the correct restriction enzymes and ligated into pMal-c2x vector (New England Biolabs), which had been previously cut appropriately. DH5α cells were again transformed and blue-white screening as before identified positive recombinant clones. DNA sequencing using an ABI 373 Prism automated sequencing system with a Big Dye terminator sequencing kit (Applied Biosystems, Foster City, California) determined nucleotide sequences of the inserts. Sequence identities were confirmed by BLAST analysis. For protein expression BL21-CodonPlus-Ril competent cells (Stratagene) were used. The transformed cells were grown in Luria-Bertani medium with 0.2% glucose, ampicillin (50 μg/mL) to maintain the expression plasmid and chloramphenicol (50 μg/mL), to an optical density at 600 nm (OD 600 ) of 0.3 to 0.5 at temperatures between 25°C and 37°C depending on the individual construct. Each culture was then induced to express the MBP-DBL/CIDR fusion proteins in the presence of 0.1 mM isopropyl-β-D-thiogalactoside (IPTG). The samples were spun and the pellet re-suspended in 1 M Tris lysis buffer. The cells were disrupted by sonication (12 pulses × 1 min). After spinning each MBP-fusion protein was purified by chromatography on amylose resin as recommended by the manufacturer (New England Biolabs), using 100 mM maltose for elution. After purification, the protein obtained was stored in the following buffer: 10 mM Tris-HCl, pH 7.4, 0.2 M NaCl, 10 mM β-mercaptoethanol, 1 mM EDTA at -80°C. Protein purity was determined by sodium dodecyl sulphate-polyacrylamide gel electrophoresis with 10% polyacrylamide and quantity was estimated by a protein assay kit (Bio-Rad, Munich, Germany) as recommended by the manufacturer.
Enzyme-linked immunosorbant assay (ELISA)
After checkerboard assays to determine the optimal coating concentration, 200 ng of DBL2β and DBL4γ and 400 ng of DBL1α, CIDR1α and DBL5β were coated onto individual wells in Nunc transparent, flat-bottomed 96 well plates (Nunc Technology) in 100 μl phosphate buffered saline (PBS). An equivalent molar concentration of MBP alone was coated as a control. In addition schizont extract of the A4 strain of Plasmodium falciparum was produced and coated onto plates in PBS using the methods described by Ndungu et al [25] . The plates were incubated overnight at 4°C, washed in PBS with 0.05% Tween 20 and blocked with 200 μl blocking buffer (10% skimmed milk in PBS with 0.5% Tween 20) for 1 hour at 37°C. The plates were washed again as before and 100 μl of human sera (diluted 1:100 with blocking buffer) was incubated in duplicate for 1 hour at 37°C. The wells were again washed and 100 μl of HRP-conjugated rabbit anti-human IgG (Dako Ltd.), at a dilution of 1:5000 was added and the plates incubated again for 1 hour at 37°C. Detection was by the addition of O-phenylenediamine/H 2 O 2 (Sigma) for 15 minutes in darkness. The mean OD value, taken at 492 nm, was calculated for each sample after correction for binding to MBP alone. A serum was scored as positive if the corrected OD value was higher than the mean + 3 SD of 20 negative control sera from UK residents who had never been exposed to malaria. All sera were screened in duplicate and a selection repeated at a later date. OD values were standardized against a pre-screened high positive standard on each plate. Please see additional files 1 and 2 for the mean OD values for the positive standards on each plate and for the range of OD values obtained with sera from 20 non-malaria exposed UK donors respectively.
Flow cytometry
Using parasite clones A4U, A4-40 cycle and 3D7 and the clinical isolate, denoted P1, cryo-preserved trophozoiteinfected erythrocytes at between 1 and 5% parasitaemia were thawed through the sequential restoration of isotonicity [26] . They were washed twice in RPMI and the pellet was resuspended at 1% haematocrit in 0.1% bovine serum albumin/phosphate-buffered saline (0.1%BSA/ PBS). 1 μl of human serum was pipetted into separate wells of a 96-well U-bottomed plate (Nunc Technology) and 9 μl of the infected erythrocyte cell suspension was added to each well giving a final test serum concentration of 1:10. The reaction mixture was incubated at room temperature for 1 hour, following which the cells were spin washed three times with 0.1%BSA/PBS. The cells were then resuspended in 25 μl 0.1%BSA/PBS containing the secondary antibody, rabbit anti-human IgG at a concentration of 1:100. Again the reaction mixture was incubated for 1 hour at room temperature after which a further three washes were performed as before. Finally 25 μl of 0.1%BSA/PBS containing a 1:100 dilution of swine antirabbit IgG coupled to FITC and 10 μg/ml of ethidium bromide was added to each well. A further incubation at room temperature in darkness, for 1 hour was done after which, following a further series of washes; at least 1,000 infected erythrocytes were counted on an EPIC/XL flow cytometer (Coulter-electronics, UK).
Reactivity against the infected erythrocyte surface was scored as mean fluorescent intensity using the method of Williams et al [27] . In detail, mean fluorescence of parasite-infected erythrocytes was determined using the formula: 
Statistical analysis
All statistical analyses were performed using Stata version 8 (Statacorp, TX, USA). To investigate the relationship between parasite status at the time of cross-sectional bleed and subsequent antibody levels, a multiple linear regression model, controlled for age, expressed as a factor of 6 months duration, location and exposure (estimated by responses to schizont extract) was performed. The results are expressed as coefficients describing the difference in antibody levels attributable to parasites.
Significant differences in two or more continuous variables were calculated using the Wilcoxon rank sum test. The Chi-squared test for trend was used to assess a trend across groups.
In a randomly selected subgroup of individuals (148 from Chonyi and 142 from Ngerenya, all ages represented), total IgG responses to erythrocytes parasitized with A4U, A4-40 cycle, 3D7 and P1 were also measured using flow cytometry. The correlation of responses to each individual domain with responses to the parasitized erythrocyte surface was assessed using the Spearman rank correlation coefficient.
In order to investigate any association of domain-specific antibody responses with protection from clinical malaria, initially the univariate association between detectable serum IgG to each antigen (measured as OD), and whether or not the individual had an episode of clinical malaria during the subsequent six months was investigated by fitting the continuous variable against a binomial distributed outcome using logistic regression. As antibody reactivity is known to increase with exposure, a multiple logistic regression was then performed with age, location and reactivity to schizont extract, as a marker of exposure, included as co-dependent variables. Results are expressed as odds ratios per 10 fold increase in antibody levels.
Results
Naturally occurring antibody responses to recombinant PfEMP1 domains
Evidence for age-associated acquisition of domain-specific IgG was apparent for responses against recombinant domains DBL1α and DBL4γ in both Ngerenya and Chonyi (Figure 1) . No appreciable increase in antibody acquisition with age was seen with CIDR1α, in either area and with responses to both DBL2β and DBL5β, the trend for increasing acquisition of responses with age was significant in the higher of the two transmission areas, Chonyi Noticeable differences could be seen in the response to the different PfEMP1 domains. For example it is clear that a greater proportion of individuals recognize DBL1α and Proportion of individuals in each age group recognizing recombinant domains Overall the number of domains recognized increased with age in both areas (Figure 2 ). In six of the age groups, individuals resident in Chonyi recognized a significantly greater number of domains. Using a multiple linear regression model, the effect of asymptomatic parasitaemia on the OD value obtained for each domain after controlling for age, location and exposure was determined. Having detectable parasites at crosssectional bleed was associated with significantly higher OD values for domains DBL1α, DBL2β and CIDR1α (Table 1) . There was no effect on antibody reactivity to DBL4γ or DBL5β. Figure 3 outlines the prevalence of responses to A4U measured by flow cytometry. Acquisition of responses
Association of asymptomatic parasitaemia and antiA4PfEMP1 antibody responses
Correlation of responses to recombinant domains with responses to the surface of erythrocytes infected with A4 parasites selected to express A4-PfEMP1
Mean number of domains recognised with age Figure 2 Mean number of domains recognised with age. Graph shows mean number of domains, plus upper 95% confidence limits, recognized by individuals in each age group. The dark grey bars refer to individuals in Chonyi and the hatched bars to individuals resident in Ngerenya. *=P-value <0.05 (Wilcoxon Ranksum). 
Association of anti-A4PfEMP1 antibody responses and protection from clinical malaria
When antibody positivity to the PfEMP1 recombinant domains was analysed as a whole within Chonyi, no association was found between antibody response and subsequent disease experience (Table 2) . When individuals were categorized by parasite status at the time of bleed, a positive association between the presence of anti-DBL1α antibodies and protection from subsequent clinical malaria was found in those parasite negative at the time of bleed. No association with protection from or susceptibility to malaria was observed with antibodies against any other recombinant domain in Chonyi and antibody responses to none of the domains were associated with protection in Ngerenya.
Discussion
PfEMP1 is currently the most plausible and best characterized of the erythrocyte surface-expressed parasite-induced proteins proposed as targets for naturally acquired protective immune responses [31] . PfEMP1 is a large, diverse and structurally complex molecule. It is composed of an intracellular, highly conserved domain and a large, extracellular variant domain. Although this extracellular domain is highly polymorphic, PfEMP1 variants share an overall common structure.
It has been hypothesized that naturally acquired immunity develops through the piecemeal acquisition of a large repertoire of antibodies directed against variants of this protein [8] . Supporting this possibility are experimental vaccination of aotus monkeys with selected domains from specific PfEMP1 variants resulting in protection against Proportion of individuals in each age group recognizing parasite line A4u Figure 3 Proportion of individuals in each age group recognizing parasite line A4u. Sera from 272 individuals older than six months, was tested for reactivity against the parasite line A4U using flow cytometry. A further study has shown that antibodies directed against recombinant domains from PfEMP1expressed from an isogenic parasite line of 3D7 increase both with intensity and age and that specifically, increased levels of anti-CIDR2β are associated with less clinical malaria [37] . In addition, Oguariri and colleagues compared the prevalence of antibodies directed against recombinant DBL1α domains from nine wild isolates in the sera of children and adults resident in an area hyperendemic for P. falciparum transmission. There was strong correlation between the age of the patients and reactivity against the recombinant DBL1α domains [38] . Here, through the use of recombinant protein technology, the naturally acquired antibody response to the extracellular domains of A4 PfEMP1 in the sera of individuals resident in two areas endemic for P. falciparum malaria but with different transmission characteristics have been evaluated.
It is clear that there are differences in the total acquisition of domain-specific antibodies and the time over which such responses are acquired both between areas and between domains. Previous studies have described an increased prevalence of antibodies to blood-stage antigens amongst individuals with detectable parasites at the time of bleed [28] [29] [30] . A similar result was obtained in this study with regard to responses to DBL1α, DBL2β and CIDR1α, but not to DBL4γ or DBL5β. This is a curious result as these recombinant domains were cloned from a laboratory parasite clone, A4. It implies that young children possess a degree of cross-reactive short-lived PfEMP1-specific antibodies capable of recognizing individual domains.
It is interesting that not only did responses to DBL4γ correlate positively with individual responses to the intact A4-parasitized erythrocyte, but that these responses were also correlated with individual responses to an alternative A4 variant expressing a more heterogenous group of var genes on the erythrocyte surface and also to an unrelated laboratory clone, 3D7 and a clinical isolate, P1. That these correlations were not found with any other recombinant domain nor related to previous exposure as far as could be determined may suggest a cross-reactive or more conserved epitope maintained within the expressed DBL4γ protein.
Despite showing clear evidence of age and exposure dependent acquisition of domain specific responses and in addition demonstrating that those responses to DBL1α and DBL4γ correlate with antibody responses to the intact 1 Results from a multiple logistic regression giving the odds ratio for becoming a case of clinical malaria in the subsequent six months if scored as antibody positive against each domain in turn controlling for for age (categorized as a factor of six months duration) and exposure (estimated by responses to whole schizont extract). An individual was deemed antibody positive if the OD obtained was greater than the mean OD plus 3 standard deviations obtained from a panel of nonexposed donors.
A4-parasitized erythrocyte, we were unable to convincing correlation with protection from clinical disease. By expressing each domain as a recombinant fusion protein in E. coli, it is likely that important conformational epitopes will not be accessible to the sera tested or equally that what is being recognized by sera are not important targets within the host Whether these antibodies are reacting to epitopes exposed by the process of cloning and expression within the bacterial system, epitopes not exposed as part of the full A4 PfEMP1 molecule, or whether this reflects methodological limitations within the affinity purification process is presently unknown.
It is difficult to know how to interpret the apparent protective relationship between responses to DBL1α in parasite negative individuals in the higher transmission setting in this study. Previous studies in this area have shown an important effect of parasite positivity on the ability to detect protective responses against several blood stage antigens [28] [29] [30] . Given that in this case the effect is in the opposite direction, it must be considered that this is a chance finding and unlikely to be biologically meaningful. 
